Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest Interventional cardiology Stories

2013-09-06 12:25:31

Coating artery-opening stents with a new compound may someday eliminate a common side effect of the treatment, according to preliminary research in the American Heart Association journal Arteriosclerosis, Thrombosis, and Vascular Biology. Stents are tiny mesh tubes that prop open clogged arteries so blood will flow freely to heart muscle, relieving chest pain and reducing the risk of heart attack. But implanting a stent damages the inner lining of the artery, triggering overgrowth of...

Faster Hospital Care Not Leading To Fewer Heart Attack Deaths
2013-09-05 10:53:25

Michael Harper for redOrbit.com - Your Universe Online Although hospitals have been successful in getting treatment to heart attack victims more quickly, the rate of death has remained relatively unchanged. The University of Michigan Frankel Cardiovascular Center has conducted a study measuring what they call “door-to-balloon” time, or the time between admission and angioplasty. In most cases hospitals are able to start surgery within 90 minutes and have worked to reduce this time...

2013-09-04 12:33:49

Company Continues to Expand Commercialization of Second-Generation Device Worldwide WILMINGTON, Del. and MUNICH, Sept. 4, 2013 /PRNewswire/ -- JenaValve Technology, Inc., a privately-held, venture-backed developer, manufacturer and marketer of transcatheter aortic valve implantation (TAVI) systems for the treatment of aortic valve disease, announced today that it has successfully completed the first three implantations of its second-generation transapical JenaValve TAVI system in Argentina....

2013-09-02 23:00:52

Worldwide study of more than 11,000 female patients provides evidence that stents can be safe and efficient in women who are traditionally underrepresented in clinical trials. New York, NY (PRWEB) September 02, 2013 Cardiac stents to open blocked heart arteries and reduce chest pain have been used for decades. However, cardiologists have never been certain that women benefitted from their use because clinical trials testing stents only included, at most, 25 percent women, making the...

2013-08-30 08:24:33

DUBLIN, August 30, 2013 /PRNewswire/ -- Research and Markets( http://www.researchandmarkets.com/research/pfqg3m/cardiovascular) has announced the addition of a new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies [http://www.researchandmarkets.com/research/pfqg3m/cardiovascular ]" to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery to the cardiovascular system is different from delivery to other...

2013-08-27 08:28:21

- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass. and SYDNEY, Aug. 27, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has approved an IDE (Investigational Device Exemption)...

2013-08-22 16:24:40

PLEASANTON, Calif., Aug. 22, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Morgan Stanley 2013 Health Care Conference on Monday, September 9. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 10:50 a.m., Pacific Daylight Time (1:50 p.m., Eastern...

2013-08-22 12:26:18

Cardiologists at Saint Luke's Repair Life-Threatening Heart Defect; Doctors at Heart Health Centre in Grand Cayman Provide Essential Rehab and Follow-up to the Open Heart Surgery KANSAS CITY, Mo., Aug. 22, 2013 /PRNewswire-USNewswire/ -- Sixteen-year-old Romario Dixon is quiet, lean, and athletic. For more than half his life, he's had a single minded passion for soccer, or football as it's called in Grand Cayman where he lives. So when doctors detected an abnormality in his heart...

2013-08-22 08:26:51

Government Reimbursement Reductions Will Continue to Limit Market Growth, According to Millennium Research Group TORONTO, Aug. 22, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, efforts to streamline the regulatory approval process in Japan have resulted in the recent entry of numerous devices in the Japanese peripheral vascular (PV) device market, and more products, such as drug-coated balloons and...

2013-08-21 08:26:53

ABBOTT PARK, Ill., Aug. 21, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that it has completed its acquisition of IDEV Technologies, a privately held company focused on developing next-generation medical devices for use by interventional radiologists, vascular surgeons and interventional cardiologists. The acquisition expands Abbott's global peripheral technology portfolio with IDEV Technologies' SUPERA Veritas(®) self-expanding nitinol stent system. SUPERA Veritas...


Latest Interventional cardiology Reference Libraries

Coronary Angiography
2013-07-29 11:05:01

A coronary angiography, also known as a coronary catheterization, is a procedure that gives both visual and tactical access to coronary circulation and blood filled chambers of the heart for both diagnostic and interventional purposes. It is one of many diagnostic tests used in cardiology. More specifically, coronary catheterization recognizes occlusion, stenosis, thrombosis or aneurismal enlargement of the walls of the coronary arteries; heart chamber size; heart muscle contraction...

More Articles (1 articles) »